1Uehlinger DE, Jakob SM, Ferrari P, et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure [J]. Nephrol Dial Transplant,2005,20 (8) : 1630-1637.
2Goldstein SL, Eurrier H, Graf JM, et al. Outcome in children receiving continuous venovenous hemofihration [J]. Pediatrics ,2001,107( 1 ) : 1309-1312.
3Lindhoff-Last E, Betz C, Bauersachs R. Use of a lowmolecular-weight heparinoid (danaparoid sodium) for continuous renal replacement therapy in intensive care patients [ J ]. Clin Appl Thromb Hemost, 2001,7 (4) : 300- 304.
4Hothi DK, St George-Hyslop C, Geary D, et al. Continuous renal replacement therapy (CRRT) in children using the AQUARIUS [J]. Nephrol Dial Transplant, 2006, 21 (8) : 2296-2300.
5Symons JM, Chua AN, Somers MJ, et al. Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry [J]. Clin J Am Soc Nephrol, 2007,2 (4) : 732-738.
6Lins RL, Elseviers MM, Van der Niepen P, et al. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial [J]. Nephrol Dial Transplant, 2009,24 (2) : 512-518.
7Bell M, Liljestam E, Granath F, et al. Optimal follow-up time after continuous renal replacement therapy in actual renal failure patients stratified with the RIFLE criteria [ J ]. Nephrol Dial Transplant, 2005,20 (2) : 354-360.
8Himmelfarb J. Continuous renal replacement therapy in the treatment of acute renal failure : critical assessment is required [J]. Clin J Am Soc Nephrol,2007,2 (3):385- 389.
9Laufer J, Ettenger RB, Ho WG, et al. Plasma exchange for recurrent nephrotic syndrome following renal transplantation [J ]. Transplantation, 1988,46 (4) : 540-542.
10Dantal J, Bigot E, Bogers W, et ol. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome [J]. N Engl J Med, 1994,330(1) :7-14.
